Related Experiment Video

Updated: Sep 21, 2026

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance
09:00

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance

Published on: May 2, 2018

Emergence of drug resistance. Impact on bacterial meningitis

K P Klugman1, S A Madhi

  • 1School of Pathology, South African Institute for Medical Research, University of the Witwatersrand, Johannesburg, South Africa. keithk@mail.saimr.wits.ac.za

Infectious Disease Clinics of North America
|September 2, 1999
PubMed

Insights

Antimicrobial resistance is increasing in major meningitis pathogens like meningococcus, Haemophilus influenzae, and pneumococcus. Treatment for resistant bacterial meningitis now requires advanced antibiotics such as third-generation cephalosporins, vancomycin, or rifampin.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Antimicrobial resistance (AMR) poses a significant threat to global health.
  • Bacterial meningitis remains a leading cause of mortality and morbidity worldwide.
  • Emergence of resistance in key bacterial pathogens complicates meningitis treatment.

Purpose of the Study:

  • To review the current landscape of antimicrobial resistance in major bacterial meningitis pathogens.
  • To highlight the clinical implications of emerging resistance patterns.
  • To inform optimal therapeutic strategies for bacterial meningitis.

Main Methods:

  • Literature review of antimicrobial resistance trends in Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae.
  • Analysis of resistance mechanisms and their impact on treatment guidelines.
  • Synthesis of current recommendations for managing resistant bacterial meningitis.

Main Results:

  • Chloramphenicol resistance is noted in Neisseria meningitidis.
  • Penicillin resistance in Neisseria meningitidis is common but its clinical significance is under investigation.
  • Haemophilus influenzae shows increasing chloramphenicol resistance and common beta-lactamase production.
  • Streptococcus pneumoniae exhibits widespread resistance to penicillin and chloramphenicol, with emerging third-generation cephalosporin resistance.
  • Third-generation cephalosporins are essential for treating resistant H. influenzae and N. meningitidis meningitis.
  • Vancomycin or rifampin addition to third-generation cephalosporins is crucial for managing resistant S. pneumoniae meningitis.

Conclusions:

  • Antimicrobial resistance is a growing challenge in treating bacterial meningitis.
  • Effective management of meningitis caused by resistant strains necessitates updated therapeutic approaches.
  • Continued surveillance and development of new treatment strategies are vital to combat resistant meningitis pathogens.

More Related Videos

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects06:42

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects

Published on: September 27, 2024

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...